Extrapancreatic Neuroendocrine Tumor

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-04-17
Clinical Trial Update: Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors [Phase 2, Phase 3]
A Phase 2/Phase 3 trial is evaluating Zanzalintinib versus Everolimus in locally advanced or metastatic neuroendocrine tumors, including pan…